Tender offer
- Sector
- Healthcare
- Industry
- Biological Products, (No Diagnostic Substances)
- Exchange
- NYSE
- State of incorporation
- P7
- Form
- SC TO-T/A
- Filed
- August 13, 2020
Deal approval & antitrust
merger-arb riskA change of control closes only once its regulators clear it. These agencies have jurisdiction given the company's sector — track each one's docket for this deal. We link the official source; we do not assert an outcome.
Filings & documents
Every entry traces to SEC EDGAR. The Information Statement is the primary source; the links below open the full filing and each company's complete filing history.
Source filing ↗SC TO-T/A · the filing we parseAll documents in this filing ↗accession 0001104659-20-094389QIAGEN N.V. — all SEC filings ↗EDGAR company pageTHERMO FISHER SCIENTIFIC INC. — 8-K announcements ↗where the spin-off was announcedTHERMO FISHER SCIENTIFIC INC. — all SEC filings ↗parent EDGAR company page